WallStSmart
STVN

Stevanato Group SpA

NYSE: STVN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$15.53
-1.71% today

Updated 2026-11-16

Market cap
$3.70B
P/E ratio
22.93
P/S ratio
2.96x
EPS (TTM)
$0.59
Dividend yield
—
52W range
$12 – $24
Volume
0.7M

Stevanato Group SpA (STVN) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price
$15.53
12-Month target
$14.34
2030 Target
—
Intrinsic (DCF)
$48.58

Financial forecast

Metric20212022202320242025
Revenue$0.8B$1.0B$1.1B$1.1B$1.1B
EPS—————
CAGR applied: — (capped 20%) · P/E: 22.93x (capped 25x) · Margin: 11.30%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.